US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 22.920
  • +0.240+1.06%
Close Feb 14 16:00 ET
  • 22.920
  • 0.0000.00%
Post 17:04 ET
1.38BMarket Cap-15.28P/E (TTM)

About Spyre Therapeutics Company

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Company Profile

SymbolSYRE
Company NameSpyre Therapeutics
Listing DateApr 7, 2016
Founded2013
CEODr. Cameron Turtle, D.Phil.
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
AddressBuilding 17,221 Crescent Street,Suite 102B
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-617-651-5940
Websitehttp://www.spyre.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cameron Turtle, D.Phil.
  • Director, President and Chief Executive Officer
  • 15.92M
  • Dr. Scott L. Burrows, M.D.
  • Chief Financial Officer and Principal Accounting Officer
  • 7.55M
  • Heidy King-Jones
  • Chief Legal Officer and Corporate Secretary
  • 6.59M
  • Jeffrey W. Albers, J.D.
  • Chairman of the Board
  • 433.57K
  • Dr. Sandra Milligan, J.D.
  • Director
  • --
  • Mark C. McKenna
  • Independent Director
  • --
  • Dr. Michael Henderson, M.D.
  • Independent Director
  • --
  • Laurie D. Stelzer, M.B.A.
  • Independent Director
  • 434.38K
  • Tomas Kiselak
  • Independent Director
  • 658.43K
  • Peter Harwin
  • Independent Director
  • 661.28K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?